Ocugen, Inc. (OCGN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:49PM EDT. Market open.
| Previous close | 1.3200 |
| Open | 1.2900 |
| Bid | 1.2900 x 100 |
| Ask | 1.3000 x 300 |
| Day's range | 1.2700 - 1.3700 |
| 52-week range | 0.3450 - 2.1050 |
| Volume | |
| Avg. volume | 8,971,411 |
| Market cap | 331.949M |
| Beta (5Y monthly) | 3.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study
Ocugen (OCGN) stock gains as the DSMB for the phase I/II study of OCU410 approves the initiation of dosing with the medium dose of OCU410 in the dose-escalation phase of the GA study.
- Insider Monkey
Ocugen, Inc. (NASDAQ:OCGN) Q3 2023 Earnings Call Transcript
Ocugen, Inc. (NASDAQ:OCGN) Q3 2023 Earnings Call Transcript November 9, 2023 Ocugen, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.08. Operator: Good morning and welcome to Ocugen’s Third Quarter 2023 Financial Results and Business Update. Please note that this call is being recorded at this time. All participants’ line are in a […]
© 2024 Yahoo. All rights reserved.